286 related articles for article (PubMed ID: 31092081)
1. Chronic obstructive pulmonary disease and comorbidities' influence on mortality in non-small cell lung cancer patients.
Media AS; Persson M; Tajhizi N; Weinreich UM
Acta Oncol; 2019 Aug; 58(8):1102-1106. PubMed ID: 31092081
[No Abstract] [Full Text] [Related]
2. Impact of chronic obstructive pulmonary disease on the mortality of patients with non-small-cell lung cancer.
Lee SJ; Lee J; Park YS; Lee CH; Lee SM; Yim JJ; Yoo CG; Han SK; Kim YW
J Thorac Oncol; 2014 Jun; 9(6):812-7. PubMed ID: 24807154
[TBL] [Abstract][Full Text] [Related]
3. The effect of different comorbidities on survival of non-small cells lung cancer patients.
Iachina M; Jakobsen E; Møller H; Lüchtenborg M; Mellemgaard A; Krasnik M; Green A
Lung; 2015 Apr; 193(2):291-7. PubMed ID: 25516286
[TBL] [Abstract][Full Text] [Related]
4. The relationship between chronic obstructive pulmonary disease and non-small cell lung cancer in the elderly.
Wang P; Zhu M; Zhang D; Guo XG; Zhao S; Zhang XL; Wang DL; Liu CT
Cancer Med; 2019 Aug; 8(9):4124-4134. PubMed ID: 31184445
[TBL] [Abstract][Full Text] [Related]
5. The impact of coexisting COPD on survival of patients with early-stage non-small cell lung cancer undergoing surgical resection.
Zhai R; Yu X; Shafer A; Wain JC; Christiani DC
Chest; 2014 Feb; 145(2):346-353. PubMed ID: 24008835
[TBL] [Abstract][Full Text] [Related]
6. Comparison of clinical characteristics and overall survival between spirometrically diagnosed chronic obstructive pulmonary disease (COPD) and non-COPD never-smoking stage I-IV non-small cell lung cancer patients.
Lim JU; Yeo CD; Rhee CK; Kang HS; Park CK; Kim JS; Kim JW; Kim SJ; Yoon HK; Lee SH
Int J Chron Obstruct Pulmon Dis; 2019; 14():929-938. PubMed ID: 31118602
[No Abstract] [Full Text] [Related]
7. The influence of psychiatric disorders on the course of lung cancer, chronic obstructive pulmonary disease and tuberculosis.
Sikjær MG; Løkke A; Hilberg O
Respir Med; 2018 Feb; 135():35-41. PubMed ID: 29414451
[TBL] [Abstract][Full Text] [Related]
8. Comparison of survival of chronic obstructive pulmonary disease patients with or without a localized non-small cell lung cancer.
Jeppesen SS; Hansen NG; Schytte T; Nielsen M; Hansen O
Lung Cancer; 2016 Oct; 100():90-95. PubMed ID: 27597286
[TBL] [Abstract][Full Text] [Related]
9. Surgical treatment for lung cancer with COPD based on the Global Initiative for Chronic Obstructive Lung Disease (GOLD).
Iwasaki A; Shirakusa T; Enatsu S; Maekawa S; Yoshida Y; Yoshinaga Y
Thorac Cardiovasc Surg; 2005 Jun; 53(3):162-7. PubMed ID: 15926096
[TBL] [Abstract][Full Text] [Related]
10. Comorbidities in lung cancer: prevalence, severity and links with socioeconomic status and treatment.
Grose D; Morrison DS; Devereux G; Jones R; Sharma D; Selby C; Docherty K; McIntosh D; Louden G; Nicolson M; McMillan DC; Milroy R;
Postgrad Med J; 2014 Jun; 90(1064):305-10. PubMed ID: 24676985
[TBL] [Abstract][Full Text] [Related]
11. Overall survival of driver mutation-negative non-small cell lung cancer patients with COPD under chemotherapy compared to non-COPD non-small cell lung cancer patients.
Lim JU; Yeo CD; Rhee CK; Kim YH; Park CK; Kim JS; Kim JW; Kim SJ; Yoon HK; Lee SH
Int J Chron Obstruct Pulmon Dis; 2018; 13():2139-2146. PubMed ID: 30034229
[TBL] [Abstract][Full Text] [Related]
12. Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease.
Deepak JA; Ng X; Feliciano J; Mao L; Davidoff AJ
Ann Am Thorac Soc; 2015 May; 12(5):742-51. PubMed ID: 25760983
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Coexisting Asthma, Chronic Obstructive Pulmonary Disease and Tuberculosis on Survival in Patients with Lung Squamous Cell Carcinoma.
Huang JY; Jian ZH; Ndi Nfor O; Jhang KM; Ku WY; Ko PC; Jan SR; Ho CC; Lung CC; Pan HH; Liang YC; Liaw YP
PLoS One; 2015; 10(7):e0133367. PubMed ID: 26196516
[TBL] [Abstract][Full Text] [Related]
14. Survival associated with chronic obstructive pulmonary disease among SEER-Medicare beneficiaries with non-small-cell lung cancer.
Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
Int J Chron Obstruct Pulmon Dis; 2019; 14():893-903. PubMed ID: 31118599
[No Abstract] [Full Text] [Related]
15. Prevalence of comorbidities in COPD patients by disease severity in a German population.
Greulich T; Weist BJD; Koczulla AR; Janciauskiene S; Klemmer A; Lux W; Alter P; Vogelmeier CF
Respir Med; 2017 Nov; 132():132-138. PubMed ID: 29229085
[TBL] [Abstract][Full Text] [Related]
16. Comorbidities and health status in individuals with and without COPD in five Latin American cities: the PLATINO study.
López Varela MV; Montes de Oca M; Halbert R; Muiño A; Tálamo C; Pérez-Padilla R; Jardim JR; Valdivia G; Pertuzé J; Menezes AM;
Arch Bronconeumol; 2013 Nov; 49(11):468-74. PubMed ID: 23856439
[TBL] [Abstract][Full Text] [Related]
17. Role of emphysema and airway obstruction in prognosis of lung cancer.
Gullón JA; Suárez I; Medina A; Rubinos G; Fernández R; González I
Lung Cancer; 2011 Feb; 71(2):182-5. PubMed ID: 20554345
[TBL] [Abstract][Full Text] [Related]
18. [Impact of Chronic Obstructive Pulmonary Disease on Risk of Recurrence in Patients with Resected Non-small Cell Lung Cancer].
Qiang G; Yu Q; Liang C; Song Z; Shi B; Guo Y; Liu D
Zhongguo Fei Ai Za Zhi; 2018 Mar; 21(3):215-220. PubMed ID: 29587946
[TBL] [Abstract][Full Text] [Related]
19. Effect of multiple comorbidities on mortality in chronic obstructive pulmonary disease among Korean population: a nationwide cohort study.
Kim Y; Kim YJ; Cho WK
BMC Pulm Med; 2021 Feb; 21(1):56. PubMed ID: 33573635
[TBL] [Abstract][Full Text] [Related]
20. Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: A population-based cohort study.
Laforest L; Roche N; Devouassoux G; Belhassen M; Chouaid C; Ginoux M; Van Ganse E
Respir Med; 2016 Aug; 117():33-9. PubMed ID: 27492511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
